关于卡塔尔中度至重度亚托皮性皮肤炎管理的专家意见
Martin Steinhoff1, Mehdi Adeli2, Hassan Riad3
1Department of Dermatology and Venereology, Hamad Medical Corporation, Weill Cornell Medicine-Qatar, Doha, Qatar.
The Journal of dermatological treatment
|September 13, 2023
概括
在卡塔尔,专家制定了管理中度至重度亚托皮炎 (AD) 的指导方针. 这些指南解决了AD的高流行率和独特的区域性湿疹类型,为医疗保健专业人员提供了一种务实的方法.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 临床实践指南 临床实践指南
背景情况:
- 无氧性皮肤炎 (AD) 是一种慢性炎症性皮肤疾病,其特点是强烈的和湿疹性病变,显著影响患者的生活质量.
- 阿尔茨海默病患者群体的异质性和临床实践的区域差异需要定制的管理策略,特别是在卡塔尔.
- 特定的AD表现,如足部湿疹和牛皮状湿疹,在卡塔尔的流行率高于欧洲或美国人口.
研究的目的:
- 制定和提出基于证据的指导方针,以适应卡塔尔的临床环境来管理中度至重度的亚型皮肤炎 (AD).
- 为卡塔尔的医疗保健专业人员提供全面和务实的框架,帮助他们为AD患者做出临床决策.
- 为了解决在卡塔尔人口中观察到的AD的独特流行病学特征.
主要方法:
- 包括皮肤科医生和免疫学家在内的专家小组利用了德尔菲技术,就管理策略达成共识.
- 共识被定义为至少75%的专家小组成员的同意或不同意.
- 经过验证的工具,如SCORing Atopic Dermatitis Index (SCORAD),皮肤病生活质量指数 (DLQI) 和Atopic Dermatitis控制工具 (ADCT) 被引用进行评估.
主要成果:
- 该指南建议对中度至重度的阿尔茨海默病采取多方面的方法,包括新的局部疗法 (Janus-kinase 抑制剂,PDE4 抑制剂) 和光疗.
- 目前批准的全身治疗包括dupilumab,baricitinib,abrocitinib和upadacitinib,预计将推出新的抗IL-13和抗IL-31疗法.
- 关键的管理原则强调患者教育,全面的过敏测试,并仔细考虑伴随性疾病.
结论:
- 制定的指导方针提供了一个全面和务实的战略,用于管理卡塔尔中度至严重的亚托皮炎.
- 这些指导方针旨在在该地区标准化和提高阿兹海默症患者的护理质量.
- 该框架支持医疗保健专业人员做出明智的决策,考虑疾病严重程度和患者特定因素.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K
Asthma: Pathogenesis and Management
439
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
439
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
332
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
332
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
COPD: Management Using Bronchodilators and Corticosteroids
241
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
241


